India’s Q1 pharma exports up 6.8% to $8.1bn; U.S. remains largest export destination
India's pharmaceutical exports increased 6.8% year-on-year to $8.1 billion in Q1, ending June. The U.S. remains the largest export destination, with NAFTA, Europe, Africa, and Latin America accounting for nearly 75% of the total exports. This growth reflects the sector's resilience and potential for further expansion in global markets.